Antony A. Riley Purchases 22,514 Shares of Forte Biosciences, Inc. (NASDAQ:FBRX) Stock

Forte Biosciences, Inc. (NASDAQ:FBRX) CFO Antony A. Riley acquired 22,514 shares of the firm’s stock in a transaction dated Thursday, November 21st. The shares were purchased at an average cost of $5.55 per share, for a total transaction of $124,952.70. Following the acquisition, the chief financial officer now directly owns 30,776 shares in the company, valued at $170,806.80. This represents a 272.50 % increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

Forte Biosciences Stock Performance

NASDAQ:FBRX opened at $16.00 on Friday. The stock’s 50 day moving average price is $5.91 and its two-hundred day moving average price is $2.69. Forte Biosciences, Inc. has a 12-month low of $4.11 and a 12-month high of $21.25.

Analyst Ratings Changes

Separately, Chardan Capital lifted their price objective on Forte Biosciences from $3.00 to $64.00 and gave the company a “buy” rating in a research report on Friday, November 15th.

About Forte Biosciences

Forte Biosciences, Inc operates as a biopharmaceutical company in the United States. The company is developing FB-102 program that addresses various autoimmune diseases, such as graft-versus-host disease, and vitiligo and alopecia areata. Forte Biosciences, Inc is headquartered in Dallas, Texas.